Company Filing History:
Years Active: 2018-2024
Title: The Innovative Contributions of Jayaprakash Karkera
Introduction
Jayaprakash Karkera is a notable inventor based in Germantown, MD (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 4 patents, Karkera's work focuses on identifying cancer patients who may benefit from specific treatments.
Latest Patents
One of Karkera's latest patents involves the use of FGFR mutant gene panels in identifying cancer patients that will be responsive to treatment with an FGFR inhibitor. This patent discloses methods for evaluating a biological sample from a patient to detect the presence of one or more FGFR mutants. Additionally, it includes kits and primers designed for identifying FGFR mutant genes in biological samples. Another significant patent provided by Karkera focuses on biological markers for predicting the likelihood of survival following treatment with abiraterone acetate in patients with castration-resistant prostate cancer (CRPC).
Career Highlights
Throughout his career, Karkera has worked with prominent companies in the pharmaceutical industry, including Janssen Pharmaceutica and Astex Therapeutics Limited. His experience in these organizations has contributed to his expertise in cancer research and treatment methodologies.
Collaborations
Karkera has collaborated with various professionals in his field, including Suso Jesus Platero and Raluca Verona. These collaborations have likely enhanced his research and development efforts in cancer treatment.
Conclusion
Jayaprakash Karkera's innovative work in cancer treatment through his patents demonstrates his commitment to improving patient outcomes. His contributions to the field are invaluable and continue to influence cancer research and therapy.